Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
出版年份 2016 全文链接
标题
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
作者
关键词
Melanoma, Ipilimumab, Oncolytic Virus, Herpes Virus Entry Mediator, Talimogene Laherparepvec
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 18, Issue 1, Pages 1-15
出版商
Springer Nature
发表日期
2016-12-17
DOI
10.1007/s40257-016-0238-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review
- (2017) Alicia Brunssen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells
- (2016) A Takasu et al. CANCER GENE THERAPY
- Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition
- (2016) Peter Kar Han Lau et al. CURRENT OPINION IN IMMUNOLOGY
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Melanoma, Version 3.2016
- (2016) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses
- (2016) Karishma Rajani et al. MOLECULAR THERAPY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma
- (2016) Hiroyuki Inoue et al. OncoImmunology
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer
- (2015) Devalingam Mahalingam et al. BMC CANCER
- Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors
- (2015) Miguel A. Villalona-Calero et al. CANCER
- Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites
- (2015) H. M. Kluger et al. CLINICAL CANCER RESEARCH
- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells
- (2015) L M E Berghauser Pont et al. GENE THERAPY
- Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer
- (2015) Se Hoon Park et al. MOLECULAR THERAPY
- Complement Inhibition Prevents Oncolytic Vaccinia Virus Neutralization in Immune Humans and Cynomolgus Macaques
- (2015) Laura Evgin et al. MOLECULAR THERAPY
- Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity
- (2015) Carolina S Ilkow et al. NATURE MEDICINE
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: A Children's Oncology Group Phase I Consortium report
- (2015) E . Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Immune checkpoint modulation: Rational design of combination strategies
- (2015) Dmitriy Zamarin et al. PHARMACOLOGY & THERAPEUTICS
- Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma
- (2015) Siwen Hu-Lieskovan et al. Science Translational Medicine
- Overcoming Resistance to Targeted Therapies in Cancer
- (2015) Keara L. Redmond et al. SEMINARS IN ONCOLOGY
- Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
- (2015) Ilkka Liikanen et al. OncoImmunology
- Designing herpes viruses as oncolytics
- (2015) Cole Peters et al. Molecular Therapy-Oncolytics
- A Phase I, multicenter, open-label trial to evaluate the safety of talimogene laherparepvec (T-VEC) injected into liver tumors
- (2015) J Randolph Hecht et al. Journal for ImmunoTherapy of Cancer
- Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1
- (2014) Filip Lim et al. CURRENT GENE THERAPY
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Final planned overall survival (OS) from OPTiM, a randomized Phase III trial of talimogene laherparepvec (T-VEC) versus GM-CSF for the treatment of unresected stage IIIB/C/IV melanoma (NCT00769704)
- (2014) Robert HI Andtbacka et al. Journal for ImmunoTherapy of Cancer
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Evolution of oncolytic viruses: novel strategies for cancer treatment
- (2013) Matthew J Atherton et al. Immunotherapy
- PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
- (2013) Erin E. West et al. JOURNAL OF CLINICAL INVESTIGATION
- PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
- (2013) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
- (2012) S. Miyamoto et al. CANCER RESEARCH
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
- (2011) M. Muthana et al. CANCER RESEARCH
- The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
- (2011) Kelley A Parato et al. MOLECULAR THERAPY
- Multifunctional nanocomplexes for gene transfer and gene therapy
- (2010) Stephen L. Hart CELL BIOLOGY AND TOXICOLOGY
- Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment
- (2010) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
- (2010) B Huang et al. GENE THERAPY
- A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers
- (2010) Jean-Simon Diallo et al. MOLECULAR THERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
- (2009) E. K. Mader et al. CLINICAL CANCER RESEARCH
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus
- (2009) R. J. Prestwich et al. JOURNAL OF IMMUNOLOGY
- Utilizing Ras Signaling Pathway to Direct Selective Replication of Herpes Simplex Virus-1
- (2009) Weihong Pan et al. PLoS One
- Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21
- (2008) Kathryn A. Skelding et al. BREAST CANCER RESEARCH AND TREATMENT
- Potent Oncolytic activity of human enteroviruses against human prostate cancer
- (2008) Linda J. Berry et al. PROSTATE
- Virotherapy of Ovarian Cancer With Polymer-cloaked Adenovirus Retargeted to the Epidermal Growth Factor Receptor
- (2007) Joanne Morrison et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started